Literature DB >> 9521821

Studies on the protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase.

J M Halleen1, H Kaija, J J Stepan, P Vihko, H K Väänänen.   

Abstract

Tartrate-resistant acid phosphatase (TRAP) is an enzyme with unknown biological function. In human tissues, its expression is restricted to bone-resorbing osteoclasts and activated macrophages. Osteoclasts secrete TRAP to the circulation during bone resorption. Reduction of the enzyme's binuclear iron center is important in regulating its activity. The purple form of the enzyme is inactive and contains two ferric ions. Mild reduction activates it to a pink form containing one ferric and one ferrous ion. Instead, strong reduction removes the iron content, resulting in a colorless, inactive enzyme. We describe spontaneous activation of the purple form to the pink form upon incubation at +37 degrees C. Further incubation results in slow inactivation of the enzyme and color change to yellowish. The enzyme purified from osteoclasts is a mixture of the purple and pink forms, but the enzyme purified from serum represents the yellowish form. We suggest that the newly synthesized enzyme is purple and reduced in the cell to the functionally active pink form. After fulfilling its biological function in the cell, the enzyme is further reduced to the yellowish form and secreted into the circulation. In the serum, further reduction would dissociate the iron content. The enzymes from osteoclasts and macrophages had similar catalytic properties, both being active as a protein tyrosine phosphatase (PTPase). The acid phosphatase (AcP) and PTPase activities were similar, and the preferred AcP substrate, pNPP, was processed in the same active site as phosphotyrosine. Our results suggest that redox-regulated PTPase activity may be a major function of TRAP in vivo. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521821     DOI: 10.1006/abbi.1998.0600

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases.

Authors:  J Ljusberg; B Ek-Rylander; G Andersson
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 2.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

3.  ACP5 (Uteroferrin): phylogeny of an ancient and conserved gene expressed in the endometrium of mammals.

Authors:  Maria B Padua; Vincent J Lynch; Natalia V Alvarez; Mark A Garthwaite; Thaddeus G Golos; Fuller W Bazer; Satyan Kalkunte; Surendra Sharma; Gunter P Wagner; Peter J Hansen
Journal:  Biol Reprod       Date:  2012-04-27       Impact factor: 4.285

4.  Localisation of high acid phosphotyrosine phosphatase activity in afferent arterioles and glomeruli of human kidney.

Authors:  Seppo Partanen
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

5.  Tartrate-resistant acid phosphatase activity and glutathione levels are modulated during hFOB 1.19 osteoblastic differentiation.

Authors:  Tatiana Salles de Souza Malaspina; Célio Xavier dos Santos; Ana Paula Campanelli; Francisco Rafael Martins Laurindo; Mari Cleide Sogayar; José Mauro Granjeiro
Journal:  J Mol Histol       Date:  2008-11-01       Impact factor: 2.611

6.  MALDI mass sequencing and biochemical characterization of Setaria cervi protein tyrosine phosphatase.

Authors:  Reeta Rai; Neetu Singh; Srikanth Elesela; Savitri Tiwari; Sushma Rathaur
Journal:  Parasitol Res       Date:  2012-10-09       Impact factor: 2.289

7.  Eccentric localization of osteocytes expressing enzymatic activities, protein, and mRNA signals for type 5 tartrate-resistant acid phosphatase (TRAP).

Authors:  Yukiko Nakano; Satoru Toyosawa; Yoshiro Takano
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

8.  Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.

Authors:  Riitta Tähtelä; J Seppänen; K Laitinen; A Katajamäki; J Risteli; M J Välimäki
Journal:  Osteoporos Int       Date:  2004-12-17       Impact factor: 4.507

9.  A simple and robust reporter gene assay for measuring the bioactivity of anti-RANKL therapeutic antibodies.

Authors:  Chuanfei Yu; Lan Wang; Yongbo Ni; Junzhi Wang
Journal:  RSC Adv       Date:  2019-12-03       Impact factor: 4.036

10.  Complex coordinated extracellular metabolism: Acid phosphatases activate diluted human leukocyte proteins to generate energy flow as NADPH from purine nucleotide ribose.

Authors:  John B Hibbs; Zdenek Vavrin; James E Cox
Journal:  Redox Biol       Date:  2016-02-02       Impact factor: 11.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.